Report

VRAY: Financial Results For Third Quarter 2017. Revising Revenue Guidance

Underlying
ViewRay Inc.

ViewRay designs, manufactures and markets the ViewRay MRIdian?. The MRIdian is a system that integrates radiation therapy with simultaneous magnetic resonance imaging (MRI). There are two generations of the MRIdian: the first generation MRIdian with Cobalt-60 based radiation beams and the second generation MRIdian Linac, with linear accelerator or linac based radiation beams. MRIdian integrates MRI technology, radiation delivery and the company's proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy and strike the target using real-time targeting throughout the treatment. The MRIdian system is sized to fit into standard radiation therapy vaults.

Provider
Zacks
Zacks

​Zacks Investment Research is a Chicago based firm with over 30 years of experience in providing institutional and individual investors with the analytical tools and financial information necessary to the success of their investment process.

Other Reports on these Companies
Other Reports from Zacks

ResearchPool Subscriptions

Get the most out of your insights

Get in touch